Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Waters Corporation (WAT)

  • SEC News
  • Jan. 12, 2026, 22:21 UTC
  • 10
  • 0 comments

New Form 425 - WATERS CORP /DE/ Filed: 2026-01-12 AccNo: 0001193125-26-010647 Size: 2 MB

Comment Full text

Revelation Biosciences Inc. (REVB)

  • SEC News
  • Jan. 12, 2026, 22:21 UTC
  • 11
  • 1 comments

Rolke James 🟢 acquired 532.8K shares of REVELATION BIOSCIENCES, INC. (REVB) at $0.90 Transaction Date: Jan 08, 2026 | Filing ID: 010648

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Jan. 12, 2026, 22:20 UTC
  • 7
  • 1 comments

Utter Christine Marie 🔴 sold 1.0K shares of PTC THERAPEUTICS, INC. (PTCT) at $76.45 Transaction Date: Jan 08, 2026 | Filing ID: 000006

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Jan. 12, 2026, 22:20 UTC
  • 10
  • 1 comments

Pauwels Eric 🔴 sold 7.3K shares of PTC THERAPEUTICS, INC. (PTCT) at $78.70 Transaction Date: Jan 08, 2026 | Filing ID: 000006

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Jan. 12, 2026, 22:20 UTC
  • 6
  • 1 comments

Klein Matthew B. 🔴 sold 2.5K shares of PTC THERAPEUTICS, INC. (PTCT) at $76.45 Transaction Date: Jan 08, 2026 | Filing ID: 000007

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Jan. 12, 2026, 22:20 UTC
  • 7
  • 1 comments

Golden Lee Scott 🔴 sold 866 shares of PTC THERAPEUTICS, INC. (PTCT) at $76.45 Transaction Date: Jan 08, 2026 | Filing ID: 000006

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Jan. 12, 2026, 22:20 UTC
  • 9
  • 1 comments

Boulding Mark Elliott 🔴 sold 6.3K shares of PTC THERAPEUTICS, INC. (PTCT) at $79.52 Transaction Date: Jan 08, 2026 | Filing ID: 000006

Comment Full text

PTC Therapeutics Inc (PTCT)

  • SEC News
  • Jan. 12, 2026, 22:20 UTC
  • 9
  • 1 comments

Almstead Neil Gregory 🔴 sold 940 shares of PTC THERAPEUTICS, INC. (PTCT) at $76.45 Transaction Date: Jan 08, 2026 | Filing ID: 000006

Comment Full text

Revelation Biosciences Inc. (REVB)

  • SEC News
  • Jan. 12, 2026, 22:17 UTC
  • 10
  • 1 comments

Zygmont Chester Stanley III 🟢 acquired 78.1K shares of REVELATION BIOSCIENCES, INC. (REVB) at $0.90 Transaction Date: Jan 08, 2026 | Filing ID: 010642

Comment Full text

LeMaitre Vascular Inc (LMAT)

  • SEC News
  • Jan. 12, 2026, 22:16 UTC
  • 8
  • 1 comments

Kamke Trent G 🟡 adjusted position in 0 shares (2 derivative) of LEMAITRE VASCULAR INC (LMAT) at $48.60 Transaction Date: Jan 08, 2026 | Filing ID: 010637

Comment Full text

Waters Corporation (WAT)

  • SEC News
  • Jan. 12, 2026, 22:15 UTC
  • 1
  • 1 comments

(10% Negative) Waters Corporation (WAT) Reports Q1 2026 Financial Results

Comment Full text

Amphastar (AMPH)

  • SEC News
  • Jan. 12, 2026, 22:15 UTC
  • 1
  • 1 comments

(80% Positive) Amphastar (AMPH) Provides Update on potential for a differentiated safety profile

Comment Full text

IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)

  • SEC News
  • Jan. 12, 2026, 22:12 UTC
  • 7
  • 1 comments

Lyssikatos Joseph P 🔴 sold 132.5K shares of Enliven Therapeutics, Inc. (ELVN) at $29.13 ($3.5M) Transaction Date: Jan 08, 2026 | Filing ID: 000001

Comment Full text

Revelation Biosciences Inc. (REVB)

  • SEC News
  • Jan. 12, 2026, 22:12 UTC
  • 7
  • 1 comments

CARVER JENNIFER 🟢 acquired 42.0K shares of REVELATION BIOSCIENCES, INC. (REVB) at $0.90 Transaction Date: Jan 08, 2026 | Filing ID: 010625

Comment Full text

IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)

  • SEC News
  • Jan. 12, 2026, 22:11 UTC
  • 7
  • 1 comments

Heyman Richard A. 🔴 sold 13.9K shares of Enliven Therapeutics, Inc. (ELVN) at $25.04 Transaction Date: Jan 08, 2026 | Filing ID: 000004

Comment Full text
  • Previous
  • 239
  • 240
  • 241
  • 242
  • 243
  • Next

Search

News categories

  • Technical Exchange News(10894)
  • Event(2282)
  • SEC News(189780)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124697)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin